Relay Therapeutics, Inc.
RLAY
$12.78
-$0.44-3.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 642.07M | 554.52M | 596.43M | 656.78M | 710.36M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.84M | 17.79M | 23.84M | 16.04M | 21.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.56M | 5.97M | 3.74M | 7.58M | 7.35M |
| Total Current Assets | 658.46M | 578.28M | 624.01M | 680.39M | 739.66M |
|
|
|||||
| Total Current Assets | 658.46M | 578.28M | 624.01M | 680.39M | 739.66M |
| Net Property, Plant & Equipment | 39.82M | 41.72M | 43.73M | 46.19M | 55.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 2.30M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.34M | 1.34M | 2.26M | 2.26M | 2.12M |
| Total Assets | 699.61M | 621.33M | 670.00M | 728.84M | 799.36M |
|
|
|||||
| Total Accounts Payable | 4.10M | 7.71M | 2.75M | 5.18M | 8.45M |
| Total Accrued Expenses | 20.91M | 13.65M | 25.13M | 23.22M | 20.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.89M | 3.77M | 3.64M | 3.53M | 5.93M |
| Total Finance Division Other Current Liabilities | 847.00K | 463.00K | 1.08M | 609.00K | 1.68M |
| Total Other Current Liabilities | 847.00K | 463.00K | 1.08M | 609.00K | 1.68M |
| Total Current Liabilities | 29.75M | 25.58M | 32.61M | 32.53M | 37.05M |
|
|
|||||
| Total Current Liabilities | 29.75M | 25.58M | 32.61M | 32.53M | 37.05M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 27.68M | 28.69M | 29.69M | 30.66M | 41.23M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 57.43M | 54.27M | 62.29M | 63.18M | 78.28M |
|
|
|||||
| Common Stock & APIC | 2.73B | 2.58B | 2.57B | 2.55B | 2.54B |
| Retained Earnings | -2.09B | -2.01B | -1.96B | -1.89B | -1.82B |
| Treasury Stock & Other | -172.00K | 733.00K | 493.00K | -163.00K | 38.00K |
| Total Common Equity | 642.18M | 567.06M | 607.71M | 665.66M | 721.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 642.18M | 567.06M | 607.71M | 665.66M | 721.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 642.18M | 567.06M | 607.71M | 665.66M | 721.08M |
|
|
|||||